Imaging in Movement Disorders
Authors:
- Baijayanta MaitiBMBaijayanta Maiti
- Joel S. PerlmutterJPJoel S. Perlmutter
- 1 February 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Continuum
- Vol. 29 (1) , 194-218
Abstract
Also introduces promising new imaging modalities and describes the current status of research. LATEST DEVELOPMENTS Iron-sensitive MRI sequences and neuromelanin-sensitive MRI can be used to directly assess the integrity of nigral dopaminergic neurons and thus may reflect disease pathology and progression throughout the full range of severity in Parkinson disease (PD). The striatal uptake of presynaptic radiotracers in their terminal axons as currently assessed using clinically approved positron emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging correlates with nigral pathology and disease severity only in early PD. Cholinergic PET, using radiotracers that target the presynaptic vesicular acetylcholine transporter, constitutes a substantial advance and may provide crucial insights into the pathophysiology of clinical symptoms such as dementia, freezing, and falls. ESSENTIAL POINTS In the absence of valid, direct, objective biomarkers of intracellular misfolded α-synuclein, PD remains a clinical diagnosis. The clinical utility of PET- or SPECT-based striatal measures is currently limited given their lack of specificity and inability to reflect nigral pathology in moderate to severe PD. These scans may be more sensitive than clinical examination to detect nigrostriatal deficiency that occurs in multiple parkinsonian syndromes and may still be recommended for clinical use in the future to identify prodromal PD if and when disease-modifying treatments become available. Multimodal imaging to evaluate underlying nigral pathology and its functional consequences may hold the key to future advances....Keywords
This publication has 86 references indexed in Scilit:
- Low nigrostriatal reserve for motor parkinsonism in nonhuman primatesExperimental Neurology, 2012
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With DementiaArchives of Neurology, 2012
- Amyloid imaging of Lewy body‐associated disordersMovement Disorders, 2010
- In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementiaNeurology, 2010
- Proposed neuroimaging criteria for the diagnosis of multiple system atrophyMovement Disorders, 2009
- T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulationNeurology, 2008
- Brain magnetic resonance imaging and manganese concentrations in red blood cells of smelting workers: Search for biomarkers of manganese exposureNeuroToxicology, 2007
- [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophyMovement Disorders, 2001
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's diseaseAnnals of Neurology, 1992